Literature DB >> 26013784

Newer antidiabetic drugs in Ramadan.

Sarita Bajaj1.   

Abstract

The management of diabetes in the month of Ramadan can be very challenging. On one hand there is the issue of fasting associated hypoglycaemia, and on the other, fasting as well as post prandial hyperglycaemia. Under such circumstances, a planned regimen needs to be followed to keep the blood glucose levels under control. The same oral antidiabetic agents that were used prior to the fast are used during Ramadan with modification in dosage and timing. With the advent of newer anti-diabetic agents, there is a good scope for better control and reduced complications.

Entities:  

Keywords:  Ramadan, diabetes, DPP-IV inhibitors, GLP-1 agonists, SGLT-2 inhibitors, hypoglycaemia.

Year:  2015        PMID: 26013784

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  1 in total

Review 1.  Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients.

Authors:  Ehab Mudher Mikhael
Journal:  J Diabetes Res       Date:  2016-08-24       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.